Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)

Clinical trial NCT00391625 · COMPLETED

Trial details

NCT number: NCT00391625
Sponsor: Shire
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2004-09-13
Primary completion: 2008-01-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.